Rob Veerhuis

1.3k total citations
15 papers, 970 citations indexed

About

Rob Veerhuis is a scholar working on Physiology, Molecular Biology and Neurology. According to data from OpenAlex, Rob Veerhuis has authored 15 papers receiving a total of 970 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Physiology, 6 papers in Molecular Biology and 5 papers in Neurology. Recurrent topics in Rob Veerhuis's work include Alzheimer's disease research and treatments (10 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Tryptophan and brain disorders (3 papers). Rob Veerhuis is often cited by papers focused on Alzheimer's disease research and treatments (10 papers), Neuroinflammation and Neurodegeneration Mechanisms (5 papers) and Tryptophan and brain disorders (3 papers). Rob Veerhuis collaborates with scholars based in Netherlands, United States and France. Rob Veerhuis's co-authors include Piet Eikelenboom, Jeroen J.M. Hoozemans, Willem A. van Gool, Annemieke J.M. Rozemüller, Eric van Exel, Riqiang Yan, Esther C.W. Breij, Christine D. Dijkstra, Lars Bø and Paul van der Valk and has published in prestigious journals such as Analytical Biochemistry, Annals of Neurology and Neurobiology of Aging.

In The Last Decade

Rob Veerhuis

14 papers receiving 954 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rob Veerhuis Netherlands 12 414 343 284 206 170 15 970
Garth E. Ringheim United States 20 336 0.8× 295 0.9× 417 1.5× 83 0.4× 219 1.3× 26 1.1k
Sigal Liraz‐Zaltsman Israel 18 182 0.4× 376 1.1× 291 1.0× 75 0.4× 177 1.0× 31 1.1k
C Zoia Italy 19 269 0.6× 241 0.7× 364 1.3× 59 0.3× 118 0.7× 36 1.1k
Tal Nuriel United States 13 378 0.9× 235 0.7× 373 1.3× 69 0.3× 103 0.6× 21 1.1k
Sofie Voet Belgium 7 172 0.4× 417 1.2× 593 2.1× 96 0.5× 348 2.0× 7 1.2k
Shawei Chen United States 14 450 1.1× 227 0.7× 655 2.3× 303 1.5× 76 0.4× 22 1.4k
Gennj Piacentino Italy 8 568 1.4× 701 2.0× 409 1.4× 49 0.2× 318 1.9× 14 1.4k
Qing Mei Wang United States 19 119 0.3× 333 1.0× 512 1.8× 172 0.8× 86 0.5× 49 1.3k
Kaifu Ke China 22 248 0.6× 285 0.8× 628 2.2× 62 0.3× 192 1.1× 72 1.3k
Rachita K. Sumbria United States 22 368 0.9× 414 1.2× 395 1.4× 34 0.2× 113 0.7× 47 1.2k

Countries citing papers authored by Rob Veerhuis

Since Specialization
Citations

This map shows the geographic impact of Rob Veerhuis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rob Veerhuis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rob Veerhuis more than expected).

Fields of papers citing papers by Rob Veerhuis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rob Veerhuis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rob Veerhuis. The network helps show where Rob Veerhuis may publish in the future.

Co-authorship network of co-authors of Rob Veerhuis

This figure shows the co-authorship network connecting the top 25 collaborators of Rob Veerhuis. A scholar is included among the top collaborators of Rob Veerhuis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rob Veerhuis. Rob Veerhuis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Harten, Argonde C. van, Wesley Jongbloed, Charlotte E. Teunissen, et al.. (2017). CSF ApoE predicts clinical progression in nondemented APOEε4 carriers. Neurobiology of Aging. 57. 186–194. 19 indexed citations
2.
Schneiders, Famke L., Emmanuel Scotet, Rob Veerhuis, et al.. (2015). Aminobisphosphonates inhibit dendritic cell-mediated antigen-specific activation of CD1d-restricted iNKT cells. Clinical Immunology. 158(1). 92–99. 2 indexed citations
3.
Dijk, Karin van, Wesley Jongbloed, Philip Scheltens, et al.. (2013). P1–133: Clusterin: An early biomarker for Alzheimer's disease?. Alzheimer s & Dementia. 9(4S_Part_5). 1 indexed citations
4.
Eikelenboom, Piet, Eric van Exel, Rob Veerhuis, et al.. (2012). Innate Immunity and the Etiology of Late-Onset Alzheimer’s Disease. Neurodegenerative Diseases. 10(1-4). 271–273. 28 indexed citations
5.
Bruggink, Kim, Wesley Jongbloed, Rob Veerhuis, et al.. (2012). Amyloid-β oligomer detection by ELISA in cerebrospinal fluid and brain tissue. Analytical Biochemistry. 433(2). 112–120. 99 indexed citations
6.
Eikelenboom, Piet, Jeroen J.M. Hoozemans, Rob Veerhuis, et al.. (2012). Whether, when and how chronic inflammation increases the risk of developing late-onset Alzheimer's disease. Alzheimer s Research & Therapy. 4(3). 15–15. 89 indexed citations
7.
Veerhuis, Rob, et al.. (2012). Direct Downregulation of CNTNAP2 by STOX1A is Associated with Alzheimer's Disease. Journal of Alzheimer s Disease. 31(4). 793–800. 33 indexed citations
8.
Eikelenboom, Piet, Rob Veerhuis, Eric van Exel, et al.. (2011). The Early Involvement of the Innate Immunity in the Pathogenesis of Lateonset Alzheimer's Disease: Neuropathological, Epidemiological and Genetic Evidence. Current Alzheimer Research. 999(999). 1–12. 79 indexed citations
9.
Eikelenboom, Piet, Eric van Exel, Jeroen J.M. Hoozemans, et al.. (2010). Neuroinflammation – An Early Event in Both the History and Pathogenesis of Alzheimer’s Disease. Neurodegenerative Diseases. 7(1-3). 38–41. 216 indexed citations
10.
Marlatt, Michael W., Jeroen J.M. Hoozemans, Rob Veerhuis, & Paul J. Lucassen. (2009). Alzheimer’s Disease and Adult Neurogenesis—Are Endogenous Stem Cells Part of the Solution?. 5(1). 12–12.
11.
Breij, Esther C.W., Rob Veerhuis, Rianka P. M. Vloet, et al.. (2008). Homogeneity of active demyelinating lesions in established multiple sclerosis. Annals of Neurology. 63(1). 16–25. 255 indexed citations
12.
Eikelenboom, Piet, Rob Veerhuis, Atoosa Familian, et al.. (2008). Neuroinflammation in Plaque and Vascular β-Amyloid Disorders: Clinical and Therapeutic Implications. Neurodegenerative Diseases. 5(3-4). 190–193. 42 indexed citations
13.
Verwey, Nicolaas A., Femke H. Bouwman, Wiesje M. van der Flier, et al.. (2008). Variability in longitudinal cerebrospinal fluid tau and phosphorylated tau measurements. Clinical Chemistry and Laboratory Medicine (CCLM). 46(9). 1300–4. 15 indexed citations
14.
Wilhelmus, Micha M.M., Wilbert C. Boelens, Matthijs Kox, et al.. (2007). Small heat shock proteins associated with cerebral amyloid angiopathy of hereditary cerebral hemorrhage with amyloidosis (Dutch type) induce interleukin-6 secretion. Neurobiology of Aging. 30(2). 229–240. 32 indexed citations
15.
Eikelenboom, Piet, et al.. (2000). Neuroinflammation and Alzheimer Disease: Clinical and Therapeutic Implications. Alzheimer Disease & Associated Disorders. 14(Supplement). S54–S61. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026